Route 92 Medical, a medical technology company focused on neurovascular intervention, announced the appointment of Raj Denhoy as Chief Financial Officer, effective immediately.

Denhoy brings more than 25 years of experience in medical technology as both a CFO and equity research analyst. He previously served as CFO at Establishment Labs Holdings Inc. (NASDAQ: ESTA) for five years, where he was responsible for finance, strategy, and investor relations.

Before joining Establishment Labs, Denhoy worked as a managing director and senior medical device equity research analyst at Jefferies LLC. He also held equity research analyst positions at J.P. Morgan Securities LLC and Piper Sandler & Co.

Denhoy holds a BA in Biology from the University of California, Berkeley, an MS in Human Physiology from Georgetown University, and an MBA from the Johnson Graduate School of Management at Cornell University.

"Raj is an accomplished financial leader with deep strategic and operational experience across medical device organizations," said Tony Chou, founder and CEO at Route 92 Medical. "His proven track record in corporate finance and in leading multinational finance teams will be invaluable as we continue to grow Route 92 Medical."

Route 92 Medical is a privately held company based in West Jordan, Utah, that develops products for neurovascular intervention procedures. The company was founded by physicians and collaborates with neurovascular clinicians to develop medical devices.